We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pay at the Start for Type IA Variation Reviews, EMA Declares
Pay at the Start for Type IA Variation Reviews, EMA Declares
December 9, 2011
As of Jan. 1, holders of European Medicines Agency (EMA) marketing authorizations for human and veterinary medicines must pay fees for type 1A variation reviews at the start of the 30-day process, the EMA says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor